Foundayo

FDA-approved GLP-1 medications and their generic active ingredients.

Definition

Orforglipron tablets, the first oral non-peptide GLP-1 receptor agonist, FDA-approved April 2026 by Eli Lilly. Daily oral dosing on empty stomach with a 30-minute fast window.

How to take Foundayo (orforglipron) →

Definition curated by Weight Loss Rankings — sourced from FDA labels and peer-reviewed PubMed literature, never AI-generated summaries.

Related terms in Drugs and brands

Wegovy
Ozempic
Rybelsus
Saxenda
Zepbound
Mounjaro
Semaglutide
Tirzepatide
Orforglipron
Retatrutide
CagriSema
Cagrilintide
Survodutide
MariTide (Maridebart Cafraglutide)
Ecnoglutide

Looking for more depth?

How to take Foundayo (orforglipron)
Browse the full GLP-1 glossary (51 terms across 8 categories)
Research articles — primary-source deep dives
Tools and calculators
Compare GLP-1 telehealth providers